Lifestyle intervention for pre-diabetic neuropathy

Diabetes Care

Volumn 29, Issue 6, 2006, Pages 1294-1299

  Smith, A Gordon ^a   Russell, James ^b   Feldman, Eva L ^b   Goldstein, Jonathan ^c   Peltier, Amanda ^b   Smith, Sheldon ^a   Hamwi, Jouhaina ^a   Pollari, Donald ^a   Bixby, Billie ^a   Howard, James ^a   Singleton, J Robinson ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; STATIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIET; DIET RESTRICTION; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE INTAKE; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; LEG; LIFESTYLE; LIPID BLOOD LEVEL; MALE; MEDICAL CARE; MEDICAL EDUCATION; NERVE CONDUCTION; NERVE FIBER; NEUROPATHIC PAIN; ORAL GLUCOSE TOLERANCE TEST; QUANTITATIVE ANALYSIS; REFLEX; SCORING SYSTEM; SENSORY ANALYSIS; SKIN BIOPSY; THIGH; VISUAL ANALOG SCALE;

AGED; BIOPSY; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; DIABETIC DIET; DIABETIC NEUROPATHIES; EXERCISE; FEMALE; HUMANS; INTERVIEWS; LIFE STYLE; MALE; MICHIGAN; MIDDLE AGED; NERVE FIBERS; PREDIABETIC STATE; SKIN; TRIGLYCERIDES; UTAH;

EID: 33746463580     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0224     Document Type: Article

References (25)

1. Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, Burt V, Curtin L, Engelgau M, Geiss L: Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 27:1591-1597, 2004
2. The Italian General Practitioner Study Group: Chronic symmetric symptomatic polyneuropathy in the elderly: a field screening investigation in two Italian regions. I. Prevalence and general characteristics of the sample. Neurology 45:1832-1836, 1995
3. Singleton JR, Smith AG, Bromberg MB: Increased prevalence of impaired glucose tolerance in patients with painful sensory neuropathy. Diabetes Care 24:1448-1453, 2001
4. Novella SP, Inzucchi SE, Goldstein JM: The frequency of undiagnosed diabetes and impaired glucose tolerance in patients with idiopathic sensory neuropathy. Muscle Nerve 24:1229-1231, 2001
5. Sumner C, Seth S, Griffin J, Cornblath D, Polydefkis M: The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 60:108-111, 2003
6. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer H, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. Diabetes Care 21:518-524, 1999
7. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002
8. Smith AG, Ramachandran P, Tripp C, Singleton JR: Epidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathy. Neurology 57:1701-1704, 2001
9. Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I, Sharma AK, Boulton AJ, King RH, Thomas PK, Ward JD: Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48:578-585, 2005
10. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 26 (Suppl. 1):S5-S20, 2003
11. Diabetes Prevention Program Research Group: The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes. Diabetes Care 22:623-634, 1999
12. Butland RJ, Pang J, Gross ER, Woodcock AA, Geddes DM: Two-, 6-, and 12-minute walking tests in respiratory disease. Br Med J (Clin Res Ed) 284:1607-1608, 1982
13. Borg G, Dahlstrom H: The reliability and validity of a physical work test. Acta Physiol Scand 55:353-361, 1962
14. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA: A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281-1289, 1994
15. Lauria G, Morbin M, Lombardi R, Borgna M, Mazzoleni G, Sghirlanzoni A, Pareyson D: Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies. Neurology 61:631-636, 2003
16. Lauria G, Cornblath DR, Johansson O, McArthur JC, Mellgren SI, Nolano M, Rosenberg N, Sommer C: EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur J Neurol 12:747-758, 2005
17. Smith AG, Singleton JR: The diagnostic yield of a standardized approach to idiopathic sensory-predominant neuropathy. Arch Intern Med 164:1021-1025, 2004
18. Dyck PJ, Davies JL, Litchy WJ, O'Brien PC: Longitudinal assessment of diabetic polyneuropathy using a composite score in the Rochester Diabetic Neuropathy Study cohort. Neurology 49:229-239, 1997
19. Navaro X, Sutherland DE, Kennedy WR: Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 42:727-736, 1997
20. Kennedy JM, Zochodne DW: Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage? Diabetes 54:830-837, 2005
21. Greene D, Arezzo J, Brown M, Zenarestat Study Group: Effect of aldose reductase inhibition on nerve conduction and morphometry in diabetic neuropathy. Neurology 53:580-591, 1999
22. Kihara M, Mitsui Y, Shioyama M, Hasegawa T, Takahashi M, Takakura S, Minoura K, Kawamura I: Effect of zenarestat, an aldose reductase inhibitor, on endoneurial blood flow in experimental diabetic neuropathy of the rat. Neuroci Lett 310:81-84, 2001
23. Kohara N, Kimura J, Kaji R, Goto Y, Ishii J, Takiguchi M, Nakai M: F-wave latency serves as the most reproducible measure in nerve conduction studies of diabetic polyneuropathy: multicentre analysis in healthy subjects and patients with diabetic polyneuropathy. Diabetologia 43:915-921, 2000
24. Smith AG, Howard JR, Kroll R, Ramachandran P, Hauer P, Singleton JR, McArthur J: The reliability of skin biopsy with measurement of intra-epidermal nerve fiber density. J Neurol Sci 228:65-69, 2005
25. McArthur J, Yiannoutsos C, Simpson DM, Adornato BT, Singer EJ, Hollander H, Marra C, Rubin M, Cohen BA, Tucker T, Navia BA, Schifitto G, Katzenstein D, Rask C, Zaborski L, Smith ME, Shriver S, Millar L, Clifford DB: A phase II trial of nerve growth factor for sensory neuropathy associated with HIV infection: AIDS Clinical Trials Group Team 291. Neurology 54:1080-1088, 2000